Aprea Therapeutics, Inc. Common stock (APRE) is a publicly traded Healthcare sector company. As of July 24, 2026, APRE trades at $0.64 with a market cap of $8.17M and a P/E ratio of -0.43. APRE moved +0.00% today. Year to date, APRE is -26.03%; over the trailing twelve months it is -67.31%. Its 52-week range spans $0.55 to $5.00. Analyst consensus is strong buy with an average price target of $4.30. Rallies surfaces APRE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest APRE news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $0.64 |
| Market Cap | $8.17M |
| P/E Ratio | -0.43 |
| EPS | $-1.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.00 |
| 52-Week Low | $0.55 |
| Volume | 30.11K |
| Avg Volume | 0 |
| Revenue (TTM) | $123.30K |
| Net Income | $-11.95M |
| Gross Margin | 0.00% |
4 analysts cover APRE: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.30.